Skip to main content
. 2017 Mar 13;90(1072):20160938. doi: 10.1259/bjr.20160938

Table 1.

Clinical characteristics of patients who underwent living-donor liver transplantation

Characteristics All (n = 32) Males (n = 14) Females (n = 18)
Cirrhosis [n (%)] 12 (37.5) 5 (35.7) 7 (38.9)
 PBC [n (%)] 4 (12.5) 1 (7.1) 3 (16.7)
 HCC [n (%)] 2 (6.3) 2 (14.3) 0 (0.0)
 FH [n (%)] 1 (3.1) 1 (7.1) 0 (0.0)
 PSC [n (%)] 1 (3.1) 0 (0.0) 1 (5.6)
 FAP [n (%)] 1 (3.1) 1 (7.1) 0 (0.0)
 AH [n (%)] 1 (3.1) 0 (0.0) 1 (5.6)
 PCKLD [n (%)] 1 (3.1) 0 (0.0) 1 (5.6)
 Both cirrhosis and HCC [n (%)] 7 (21.9) 4 (28.6) 3 (16.7)
 Both FH and AH [n (%)] 1 (3.1) 0 (0.0) 1 (5.6)
 Unknown [n (%)] 1 (3.1) 0 (0.0) 1 (5.6)
Child–Turcotte–Pugh class
 A (5–6 points) [n (%)] 4 (12.5) 3 (21.4) 1 (5.6)
 B (7–9 points) [n (%)] 6 (18.8) 2 (14.3) 4 (22.2)
 C (10–15 points) [n (%)] 22 (68.8) 9 (64.3) 13 (72.2)
Post-operative respiratory CC [n (%)] 17 (53.1) 8 (57.1) 9 (50.0)
 Only pneumonia [n (%)] 3 (9.4) 2 (14.3) 1 (5.6)
 Only tracheotomy [n (%)] 0 (0.0) 0 (0.0) 0 (0.0)
 Only extubation delay [n (%)] 10 (31.3) 5 (35.7) 5 (27.8)
 Pneumonia and tracheotomy [n (%)] 0 (0.0) 0 (0.0) 0 (0.0)
 Pneumonia and extubation delay [n (%)] 2 (6.3) 0 (0.0) 2 (11.1)
 Tracheotomy and extubation delay [n (%)] 2 (6.3) 1 (7.1) 1 (5.6)
 Pneumonia, tracheotomy and extubation delay [n (%)] 0 (0.0) 0 (0.0) 0 (0.0)

AH, autoimmune hepatitis; CC, complications; FAP, familial amyloid polyneuropathy; FH, fulminant hepatitis; HCC, hepatocellular carcinoma; PBC, primary biliary cirrhosis; PCKLD, polycystic kidney and liver disease; PSC, primary sclerosing cholangitis.